13.54USD-0.07%Mkt Cap: 3.56B $P/E: 14.561d ago
Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, …
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/E
Cheaper
P/B
Cheaper
Div Yield
Higher
1M Perf
Avg
$1.07TUSDP/E 42.6
$611.36BUSDP/E 29.4
$444.21BUSDP/E 123.9
$308.01BUSDP/E 21.1
$317.37BUSDP/E 36.2
$281.52BUSDP/E 22.5
$275.65BUSDP/E 22.4
$269.91BUSDP/E 28.1
$237.69BUSDP/E 28.0
$202.85BUSDP/E 11.5
$195.44BUSDP/E 25.2
$156.86BUSDP/E 17.2
$137.24BUSDP/E 18.4
$117.66BUSDP/E 16.1
$97.68BUSDP/E 19.0
$86.27BUSDP/E 14.0
$51.69BUSD
$31.90BUSDP/E 23.3
MRV
Marvell Technology, Inc.$30.93BUSDP/E 11.7
$11.35BUSDP/E 22.7
$11.02BUSDP/E 19.1
$10.98BUSDP/E 19.1
$6.60BUSDP/E 14.6
$3.03BUSDP/E 18.5
$54.86MUSD
$39.77MUSD
ELXR
Elixxer Ltd.$9.51MUSD
CELG-RI
Bristol-Myers Squibb Company Ce—
PHOO
Photocure ASA—
FLXN
Horizon Flexible Income ETF—P/E 27.2
ROSE
DocMorris AG—
Indicators:|
Key Statistics
Company
Market Cap3.56B $
Enterprise Value11.01B $
Revenue (TTM)6.16B $
Gross Profit3.31B $
Net Income (TTM)187.00M $
Revenue/Share23.69 USD
Last Price13.54 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees10.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)14.56
P/E (Forward)3.72
PEG—
EV/EBITDA6.90
EV/Revenue1.79
P/S0.58
P/B3.94
EPS (TTM)0.93
EPS (Forward)3.64
52W Range
5.690100% of range13.55
52W High13.55 USD
52W Low5.690 USD
Profitability
Gross Margin53.30%
Oper. Margin18.70%
EBITDA Margin25.88%
Profit Margin3.01%
ROE24.87%
ROA1.45%
Growth
Revenue Growth-3.50%
Earnings Growth66.70%
Cash Flow & Leverage
Operating CF700.00M $
CapEx (TTM)316.00M $
FCF Margin8.59%
FCF Yield14.88%
Net Debt7.45B $
Net Debt/EBITDA4.67
Balance Sheet
Debt/Equity11.49
Current Ratio1.97
Quick Ratio1.00
Book Value/Sh3.438 USD
Cash/Share4.250 USD
Dividends
Fwd Div Rate0.0800 USD
Trail. Div Rate0.0800 USD
Div. Yield0.59%
5Y Avg Yield—
Payout Ratio8.60%
Ex-Div DateMay 11, 2026
Pay DateJun 11, 2026
Analyst Consensus
Rating3.2 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.25 USD
Upside (mean)-16.9%
Target Range8.000 USD – 14.00 USD
$8.000-16.9% to mean$14.00
# Analysts4
Ownership
Shares Out.262.61M
Float261.08M
Insiders0.47%
Institutions77.93%
Short Interest
Short Ratio6.9d
Short % Float8.23%
Short % Out.7.24%
Shares Short19.01M
Short (prev mo.)20.04M
Technical
SMA 5012.92 (+4.8%)
SMA 2009.196 (+47.2%)
Beta1.54
S&P 52W Chg20.05%
Avg Vol (30d)1.91M
Avg Vol (10d)2.50M
Technical Indicators
RSI (14)73.6
MACD0.1993
MACD Signal0.2595
MACD Hist.-0.0602
BB Upper13.54 USD
BB Middle13.43 USD
BB Lower13.33 USD
BB Width1.59%
ATR (14)0.0843 USD
Vol Ratio (20d)0.73x